Marco A. Ruiz Andia, MD, MPH, FACP, FIDSA
Advertisement

Marco A. Ruiz Andia, M.D., MPH, FACP, FIDSA, is chief of HIV Oncology and HIV Stem Cell Transplantation at Miami Cancer Institute as well as an attending physician in the BMT unit. Dr. Ruiz is a medical oncologist specializing in the treatment of hematologic cancers, including leukemia, lymphoma, myelodysplastic syndrome and myelofibrosis, as well as cancer combined with human immunodeficiency virus (HIV). He is an associate professor at Florida International University’s Herbert Wertheim College of Medicine.
Articles by Marco A. Ruiz Andia, MD, MPH, FACP, FIDSA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5

